Decentralized trials and biotech product needs are changing how investigational products reach patients. New market research reveals trends.
- Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development
- On The Potency Assurance Journey, Travelers Need A Road Map
- Guidelines For Defining A Control Strategy Framework For Accelerated mAb Programs
- A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
- Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Speed To Market – API Large-Scale Commercial Manufacturing
Learn how a top 20 US-based pharma company achieved more capacity to meet commercial supply needs in an accelerated timeline followed by pre-approval inspection with the help of a CMO partner.
-
Specializing In Small And Early-Stage Partners, Not Just Small Batches
Many small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.
-
Overcoming Inventory Challenges For A Complex, Global Study
Explore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.
-
Common RTSM/IRT AN Medication Pooling Questions Answered
Whether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.
-
Blinded Randomization And Trial Supply Management Gets Support
Uncover how this global specialty pharmaceutical company was able to ensure the confidentiality of its blinded study data while receiving flexible and scalable unblinded support.
-
Advantages Of Robotic Aseptic Processing
Examine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
Bespoke RTSM Systems Empower Precision Medicine
Randomization & trial supply management (RTSM) are critical functions of clinical trial IRT systems, supporting patient randomization plus managing drug inventory, site resupply, and participant dispensation.
-
Considerations When Selecting An Interactive Response Technology Provider
Interactive response technology (IRT) systems ensure clinical trial participants receive the correct treatment, facilitate enhanced logistics tracking, and empower users to obtain real-time data.
-
Overcoming The Challenges Of Fragmented Supply Chains
As trials grow more complex, managing clinical supplies is increasingly challenging. In this webinar, experts discussed GxP inventory management and integrated solutions to overcome these hurdles.
-
Key Considerations For Emerging Companies When Selecting Packaging Components
Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.